中國銀河國際:重申國泰君安國際(1788.HK)目標價1.33港元 評級“增持”
格隆匯6月11日丨中國銀河國際昨日發研報指,國泰君安國際(1788.HK)股價今年的表現與港交所(漲幅18.6%)相比,有超過48%的較大的上升空間。中國銀河國際認為,近期市場的反彈應該會緩解投資者對公司孖展融資業務和投資做市業務的擔憂。此外,國泰君安國際是京東本次上市的聯席賬簿管理人和牽頭經辦人,該行認為,港股年初至今強勁的平均日成交量,以及中概股迴歸二次上市,將令公司受益。且自4月來公司進行2000萬股回購,顯示公司對整體業務發展信心。該行重申予其“增持”評級和目標價1.33港元(2020年底市帳率0.89倍)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.